FluMist Quadrivalent Patient Counseling Information

Advise the vaccine recipient or caregiver to read the approved patient labeling (Information for Patients and Their Caregivers).
Inform vaccine recipients or their parents/guardians of the need for two doses at least 1 month apart in children 2 through 8 years of age, depending on vaccination history.
Asthma and Recurrent Wheezing: Ask the vaccinee or their parent/guardian if the vaccinee has asthma. For children younger than 5 years of age, also ask if the vaccinee has recurrent wheezing since this may be an asthma equivalent in this age group. Inform the vaccinee or their parent/guardian that there may be an increased risk of wheezing associated with FluMist Quadrivalent in persons younger than 5 years of age with recurrent wheezing and persons of any age with asthma [see Asthma, Recurrent Wheezing, and Active Wheezing under Precautions].
Vaccination with a Live Virus Vaccine: Inform vaccine recipients or their parents/guardians that FluMist Quadrivalent is an attenuated live virus vaccine and has the potential for transmission to immunocompromised household contacts.
Adverse Event Reporting: Instruct the vaccine recipient or their parent/guardian to report adverse reactions to their healthcare provider.